ChemoTech is a R&D based company in the field of oncology. The Company is presently marketing and selling it's IQwave™ TSE™ (Tumour Specific Electroporation) device which is an innovation within the field of electroporation. ChemoTech's products are presently available in Europe, India and South East Asia. The treatment is developed to treat patients with large and 'hard to treat' superficial tumours. ChemoTech's shares (CMOTEC B) are listed on NASDAQ First North in Stockholm. The company is headquartered in Lund, Sweden. We have also created a device for our Animal Care division called vetIQure™, this device is being marketed and handled by our subsidiary Vetiqure AB. Our vision By being devoted to clinical development and scientific excellence, ChemoTech aspires to be a force for better cancer care. Our aim is to always deliver cost and treatment efficient technologies that improve the quality of live to those suffering from cancer and their love ones.